Atlas Trials

Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)

Clinical trial NCT03229798 · COMPLETED

Trial details

NCT number
NCT03229798
Sponsor
Sorrento Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraine Disorders
Start date
2018-01-17
Primary completion
2018-03-28
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.